FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

The United States government has discontinued its free at-home COVID-19 test program after four years. The program, which began in 2021, shipped over 900 million tests directly to U.S. households.